At meeting held on 08 January 2018
The Board of Aarti Drugs has approved buyback of up to 2.75 lakh fully paid equity shares of face value of Rs 10 each at a price of Rs 875 per share for an aggregate amount of up to Rs 24.06 crore.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
